Compositions and methods comprising aspartyl-tRNA synthetases having noncanonical biological activities

Details for Australian Patent Application No. 2010236913 (hide)

Owner aTyr Pharma, Inc.

Inventors Adams, Ryan A.; Hong, Fei; Zhao, Ji; Piehl, Kristi; Armour, Eva R.; D'Arigo, Kenny; Greene, Leslie A.; Merriman, Eve

Agent Davies Collison Cave

Pub. Number AU-A-2010236913

PCT Pub. Number WO2010/120509

Priority 61/165,194 31.03.09 US

Filing date 31 March 2010

Wipo publication date 21 October 2010

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

A61K 38/43 (2006.01) Medicinal preparations containing peptides - Enzymes

C12N 9/10 (2006.01) Enzymes, e.g. ligases (6.) - Transferases (2.)

C12N 15/54 (2006.01) Mutation or genetic engineering - Transferases (2)

G01N 33/573 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for enzymes or isoenzymes

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

20 October 2011 PCT application entered the National Phase

  PCT publication WO2010/120509 Priority application(s): WO2010/120509

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010236914-System and method for communicating about a wellsite

2010236911-System and method for communicating about a wellsite